Relative Strength Chart Marker Therapeutics, Inc.
Equities
MRKR
US57055L2060
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.460 USD | +1.39% |
|
0.00% | -2.01% |
| 03-18 | Marker Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-17 | Marker Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MARKER THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +1.39% | 0.00% | -2.01% | +28.07% | -92.98% | 24.01M |  | |  |
- Stock Market
- Equities
- MRKR Stock
- Charts Marker Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition